Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…Exposure to Mtb H37Rv and HN878 decreased claudin V expression compared to uninfected controls in the frontal cortex (E), cerebral nuclei (J), brain stem (O), thalamus (T), and hippocampus (Y). …”

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…Additionally, there is an increase in plaque size mainly observed in the olfactory, hippocampal, cortical, and striatal areas. (D) Long-term treatment with a high dose of netoglitazone displays a decrease in plaque size, particularly observed in the orbital cortex, olfactory area, hippocampus, thalamus, hypothalamus, midbrain, and hindbrain regions.…”

Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0. by Danielle Sambo (6077924)

Astrocytes increase contact with vessels and expression of AQP4 following Mtb infection, which is decreased in cytosis⁺ animals. by Amanda S. Latham (12093638)

“…Decreased expression of AQP4, and endfoot contact, is found in cytosis⁺ animals in the frontal cortex (D and E), cerebral nuclei (J and K), brain stem (P and Q), thalamus (V and W) and hippocampus (BB and CC). …”

Acute starvation decreases the Brp::rGFP heterogeneity level among γcompartments. by Hongyang Wu (8856740)

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”

ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

<i>Toxoplasma gondii</i> chronic infection decreases visceral nociceptive responses in the absence of macroscopic colonic inflammation. by Alexis Audibert (21213531)

Deletion of C3 and C3aR reversed <i>S. aureus</i>-induced decrease in synapse density and increase in microglial phagocytosis of synapses. by Haifang Zhang (314544)

Pan-neuronal <i>dMaf1</i> knockdown decreases <i>dMaf1</i> mRNA level in brains and consistently extends lifespan. by Bowen Xu (5903801)

SBP3 KD decreases cytoadhesion of iRBCs to bovine brain endothelial cells (BBECs). by Atefeh Fathi (7370876)

Toxoplasma infection leads to a decrease in the concentration of EVs. by Emily Z. Tabaie (16630841)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…<b>(B-C)</b> Microscopic imaging confirmed the inhibition of colony formation in U87MG cells following SHG-44 treatment, with no colonies evident. <b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”

Conditional knockout of SLAMF5 in CX3CR1^er cells attenuates EAE progression, reduces brain myeloid cell activation, and decreases T cell infiltration. by Laura Bellassen (22209109)

SBP3 KD decreases the surface localization of VESA-1. by Atefeh Fathi (7370876)

Original 2D MRI views of the brain. by Muhammad Zubair (728141)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

“…(C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque count, particularly in the hindbrain, midbrain, striatum, and olfactory areas. (D) Long-term treatment with a high dose of netoglitazone demonstrates a considerable decrease in plaque count, especially in the olfactory, striatum, pallidum, hindbrain, and midbrain regions.…”

RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. by Will Campodonico (20485651)

Subjects:

Reproducibility of response time and brain measures. by Jan Willem Koten (17743224)

Statins resulted in smaller neuronal soma size. by Shuk C. Tsoi (21192243)

Subjects: